跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ORAL-B GUM THERAPY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ORAL-B GUM THERAPY
Authorized
STANDARD
ORAL-B GUM THERAPY
procter & gamble inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
51e7cf6a97c3dd25
Company
procter & gamble inc
Type
Standard
Approval Details
Approval Id
51e7cf6a97c3dd25
Drug Approval Canada Name
ORAL-B GUM THERAPY
Product Name
ORAL-B GUM THERAPY
Status
Marketed
Status Date
2021-07-05
Original Market Date
2021-07-05
Din
02510871
Drug Class
Human
Dosage Form
Mouthwash
Route Of Administration
Dental
Schedule
OTC
Ahfs
52:28.00
Atc Original
R02AA06 CETYLPYRIDINIUM
Atc Name
r 02 aa 06
Aig Number
0106834010
Company Name
procter & gamble inc
Company Address
5160 Yonge Stree 14th Floor P.O. Box 355 Station A, Toronto, Ontario, Canada, M5W 1C5
Active Ingredients
CETYLPYRIDINIUM CHLORIDE
0.07 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
51e7cf6a97c3dd25
Type
Standard
Back to Health Canada Approvals